These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 28621766)

  • 1. Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis.
    Muraro PA; Martin R; Mancardi GL; Nicholas R; Sormani MP; Saccardi R
    Nat Rev Neurol; 2017 Jul; 13(7):391-405. PubMed ID: 28621766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline.
    Bayas A; Berthele A; Blank N; Dreger P; Faissner S; Friese MA; Gerdes LA; Grauer OM; Häussler V; Heesen C; Janson D; Korporal-Kuhnke M; Kowarik M; Kröger N; Lünemann JD; Martin R; Meier U; Meuth S; Muraro P; Platten M; Schirmer L; Stürner KH; Stellmann JP; Scheid C; Bergh FT; Warnke C; Wildemann B; Ziemssen T
    Ther Adv Neurol Disord; 2023; 16():17562864231180730. PubMed ID: 37780055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis.
    Ross LA; Stropp LM; Cohen JA
    Neurol Clin; 2024 Feb; 42(1):165-184. PubMed ID: 37980114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multiple sclerosis: interventions to halt disease : Which patients can be considered for autologous stem cell transplantation].
    Willison AG; Meuth SG
    Nervenarzt; 2022 Oct; 93(10):987-999. PubMed ID: 35951049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis, the Ottawa Protocol.
    Puyade M; Brunet F; Carolina R; Fergusson N; Makedonov I; Freedman MS; Atkins H
    Curr Protoc; 2022 May; 2(5):e437. PubMed ID: 35594180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous haematopoietic stem cell therapy for multiple sclerosis: a review for supportive care clinicians on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation.
    Ismail A; Sharrack B; Saccardi R; Moore JJ; Snowden JA
    Curr Opin Support Palliat Care; 2019 Dec; 13(4):394-401. PubMed ID: 31599815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous hematopoietic stem cell transplantation for multiple sclerosis: A current perspective.
    Bose G; Thebault S; Rush CA; Atkins HL; Freedman MS
    Mult Scler; 2021 Feb; 27(2):167-173. PubMed ID: 32364422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haematopoietic Stem Cell Transplantation for Multiple Sclerosis: Current Status.
    Mariottini A; De Matteis E; Muraro PA
    BioDrugs; 2020 Jun; 34(3):307-325. PubMed ID: 32166703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous hematopoietic stem cell transplantation in multiple sclerosis: 20 years of experience.
    Currò D; Mancardi G
    Neurol Sci; 2016 Jun; 37(6):857-65. PubMed ID: 27071689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis: Recent Advances.
    Mariottini A; De Matteis E; Cencioni MT; Muraro PA
    Curr Neurol Neurosci Rep; 2023 Sep; 23(9):507-520. PubMed ID: 37589918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare utilization and costs associated with autologous haematopoietic stem cell transplantation in Norwegian patients with relapsing remitting multiple sclerosis.
    Gottschlich KN; Zolic-Karlsson Z; Aas E; Kvistad SAS; Bø L; Torkildsen Ø; Lehmann AK
    Mult Scler Relat Disord; 2024 Apr; 84():105507. PubMed ID: 38412758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant.
    Massey JC; Sutton IJ; Ma DDF; Moore JJ
    Front Immunol; 2018; 9():410. PubMed ID: 29593711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress and prospects for the use and the understanding of the mode of action of autologous hematopoietic stem cell transplantation in the treatment of multiple sclerosis.
    Collins F; Kazmi M; Muraro PA
    Expert Rev Clin Immunol; 2017 Jun; 13(6):611-622. PubMed ID: 28277827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis.
    Lycke J; Lenhoff S
    Ther Adv Neurol Disord; 2020; 13():1756286420929467. PubMed ID: 32636931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing-remitting multiple sclerosis.
    Mariottini A; Nozzoli C; Carli I; Landi F; Gigli V; Repice AM; Ipponi A; Cecchi M; Boncompagni R; Saccardi R; Massacesi L
    Neurol Sci; 2024 Jul; 45(7):3379-3387. PubMed ID: 38277051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intense immunosuppression followed by autologous haematopoietic stem cell transplantation as a therapeutic strategy in aggressive forms of multiple sclerosis.
    Mancardi G; Sormani MP; Muraro PA; Boffa G; Saccardi R
    Mult Scler; 2018 Mar; 24(3):245-255. PubMed ID: 29125439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune cell reconstitution following autologous hematopoietic stem cell transplantation in multiple sclerosis.
    Mariottini A; Cencioni MT; Muraro PA
    Handb Clin Neurol; 2024; 202():55-74. PubMed ID: 39111918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis.
    Massey J; Jackson K; Singh M; Hughes B; Withers B; Ford C; Khoo M; Hendrawan K; Zaunders J; Charmeteau-De Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I
    Front Immunol; 2022; 13():798300. PubMed ID: 35197974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study.
    Tolf A; Gauffin H; Burman J; Landtblom AM; Flensner G
    PLoS One; 2024; 19(2):e0297573. PubMed ID: 38324607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous haematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis.
    Mariottini A; Bulgarini G; Forci B; Innocenti C; Mealli F; Mattei A; Ceccarelli C; Repice AM; Barilaro A; Mechi C; Saccardi R; Massacesi L
    Eur J Neurol; 2022 Jun; 29(6):1708-1718. PubMed ID: 35146841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.